The transition metal oxide, such as iron oxide and Fe2O3/Al2O3 is cheap and industrialized that are widely used to catalyze the reaction of chlorine and oxygen with hydrogen in mixture gas to remove hydrogen from tail chlorine at low temperature. The reaction gas was prepared by the same composition with industrial tail chlorine, namely Cl2 (65% ~ 80%), O2 (8% ~ 10%), N2 (6% ~16%) and H2 (1.5% ~ 4%). In this experiment, the fixed bed reactor and iron oxide or Fe2O3/Al2O3 were used as the reaction device and catalysts, respectively. The optimum conversion rate of hydrogen was 84.11% when the reaction temperature was at 70 °C with 3%wt. Fe2O3/Al2O3 and the calcination temperature was 500 °C. The results showed that the catalytic performance of Fe2O3/Al2O3 is superior to Fe2O3. The selectivity of the reaction of hydrogen and chloride was higher than that of hydrogen and oxygen. We also characterized the catalysts with XRD, XPS, SEM and N2 adsorption-desorption and the results showed that the iron oxide was dispersive uniformly on the support surface.

Abstract Purpose: To establish a new rat model, the pathogenesis of which is closer to the clinical occurrence of chronic obstructive jaundice with liver fibrosis. Methods: 90 SD rats were randomly divided into 3 groups. Group A common bile duct ligation, group B common bile duct injection compont and group C injection saline. The serum of three groups was extracted, and the liver function was detected by ELISA. HE staining, Masson staining and immunohistochemistry were used to detect liver pathology. Results: Group B showed a fluctuant development of jaundice, obstructive degree reached a peak at 2 weeks, and decreased from 3 weeks. HA, LA and PCIII were significantly higher than control group. 3 weeks after surgery, liver tissue fibrosis occurred in group B, and a wide range of fiber spacing was formed at 5 weeks. Immunohistochemistry showed that hepatic stellate cells were more active than the control group. Conclusion: Intra-biliary injection of Compont gel is different from the classic obstructive jaundice animal model caused by classic bile duct ligation, which can provide an ideal rat model of chronic obstructive jaundice with liver fibrosis.

The aim of this study was to evaluate the influence of artesunate on Th1 differentiation and its anti-tumor effect on ovarian cancer. A Murine ovarian cancer model was established by ID8 cells transplantation. The expression of miR-142 and Sirt1 proteins in peripheral CD4+ T cells were quantified with qRT-PCR and western blot, respectively. Peripheral CD4+ T cells were induced for Th1 differentiation. The percentages of apoptosis of Th1/CD4+ T cells and ovarian cancer cells were analyzed by flow cytometry. The IFN-γ level was examined through enzyme-linked immunosorbent assay. Artesunate promoted miR-142 expression in peripheral CD4+ T cells and Th1 differentiation from CD4+ T cells. Artesunate promoted cell apoptosis of ovarian cancer cells by inducing Th1 differentiation. By up-regulating miR-142, artesunate suppressed Sirt1 level and promoted Th1 differentiation. Artesunate enhanced the pro-apoptotic effects of Th1 cells on ovarian cancer via the miR-142/Sirt1 pathway. Artesunate promoted Th1 differentiation from CD4+ T cells by down-regulating Sirt1 through miR-142, thereby enhancing cell apoptosis in ovarian cancer.

By reaction of 5-methoxysalicylaldehyde with 3-chlorobenzohydrazide and 3-methylbenzohydrazide, respectively, two structurally similar hydrazone compounds, 3-chloro-N'-(2-hydroxy-5-methoxybenzylidene)benzohydrazide (1) and N'-(2-hydroxy-5-methoxybenzylidene)-3-methylbenzohydrazide (2), were synthesized. The compounds were characterized by elemental analyses, infrared and UV-vis spectra, and single crystal X-ray diffraction. The crystal of 1 crystallizes in monoclinic space group P2/n, with unit cell dimensions a = 5.8872(8) Å, b = 31.649(2) Å, c = 7.6309(9) Å, β = 94.427(2)°, V = 1417.6(3) ų, Z = 4, R1 = 0.0462, wR2 = 0.1053. The crystal of 2 crystallizes in orthorhombic space group Pbca, with unit cell dimensions a = 10.415(1) Å, b = 9.781(1) Å, c = 29.548(2) Å, V = 3010.2(5) ų, Z = 8, R1 = 0.0519, wR2 = 0.1577. The compounds were assayed for antibacterial (Bacillus subtilis, Escherichia coli, Pseudomonas fluorescence and Staphylococcus aureus) and antifungal (Aspergillus niger and Candida albicans) activities by MTT method.

Two new carbohydrazone derivatives, N'-(3,5-dibromo-2-hydroxybenzylidene)-2-fluorobenzohydrazide (1), and N'-(4-diethylamino-2-hydroxybenzylidene)-2-fluorobenzohydrazide (2), were prepared by the reaction of 2-fluorobenzohydrazide with 3,5-dibromo-2-hydroxybenzaldehyde and 4-diethylamino-2-hydroxybenzaldehyde, respectively. The compounds were characterized by elemental analyses, infrared spectra, and single crystal X-ray diffraction. The crystal of 1 crystallizes in monoclinic space group C2/c, with unit cell dimensions a = 36.0853(5) Å, b = 10.1711(2) Å, c = 17.3627(5) Å, β = 109.973(2)°, V = 5989.3(2) ų, Z = 16, R1 = 0.0544, wR2 = 0.1300. The crystal of 2 crystallizes in monoclinic space group P2l/c, with unit cell dimensions a = 10.6827(2) Å, b = 16.5256(3) Å, c = 9.8174(1) Å, β = 102.564(2)°, V = 1691.64(5) ų, Z = 4, R1 = 0.0772, wR2 = 0.2156. The compounds were assayed for antibacterial (Bacillus subtilis, Escherichia coli, Pseudomonas fluorescence and Staphylococcus aureus) and antifungal (Aspergillus niger and Candida albicans) activities by MTT method.

Schiff base ligands 2-bromo-4-chloro-6-[(2-piperidin-1-ylethylimino)methyl]phenol (BCP) and 2,4-dibromo-6-[(2-morpholin-4-ylethylimino)methyl]phenol (DBP) and their nickel(II) and copper(II) complexes [Ni(BCP)2(CH3OH)2]2NO3 (1) and [Cu(DBP)2] (2), have been prepared and characterized by elemental analyses, IR, and single crystal X-ray crystallographic determination. The crystal of (1) is orthorhombic: space group Pbcn, a = 23.894(1), b = 8.244(2), c = 19.900(2) Å, V = 3919.9(10) Å3, Z = 4. The crystal of (2) is monoclinic: space group P2(1)/c, a = 7.072(2), b = 15.426(3), c = 14.214(3) Å, β = 96.718(2)°, V = 1540.0(7) Å3, Z = 2. The Schiff bases coordinate to the metal atoms through the phenolate O and imine N atoms. The Ni atom in (1) is in an octahedral coordination, and the Cu atom in (2) is in a square planar coordination.

A pair of new dioxomolybdenum(VI) complexes, [MoO2L¹(MeOH)HMoO2L¹(EtOH)] (1) and [MoO2L²(MeOH)HMoO2L²(EtOH)] (2), where L¹ and L² are the dianionic forms of N'-(2-hydroxy-3-methoxybenzylidene)-2-hydroxy-3-methylbenzohydrazide and N'-(3-ethoxy-2-hydroxybenzylidene)-2-hydroxy-3-methylbenzohydrazide, respectively, have been synthesized and characterized by elemental analysis, FT-IR spectra, and single crystal X-ray determination. The crystal of (1) is triclinic: space group P-1, a = 8.106(2), b = 13.412(3), c = 18.045(3) Å, α = 83.634(2), β = 84.809(2), γ = 87.746(2)°, V = 1941.0(7) ų, Z = 2, R1 = 0.0382, wR2 = 0.0919. The crystal of (2) is triclinic: space group P-1, a = 7.350(2), b = 11.292(3), c = 24.914(3) Å, α = 85.213(2), β = 82.411(2), γ = 71.012(2)°, V = 1936.1(7) ų, Z = 2, R1 = 0.0425, wR2 = 0.0877. The Mo atoms in the complexes are coordinated by one phenolate O, one imine N and one enolic O atoms of the benzohydrazone ligand, two oxo O atoms, and one solvate O atom, forming octahedral coordination. In the crystal structures, adjacent two complex molecules are linked by methanol and ethanol ligands through intermolecular O-H-O hydrogen bonds, forming dimers. The catalytic property of sulfoxidation for the complexes was studied.